Renovorx to present at the 43rd annual canaccord genuity growth conference

Los altos, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a clinical-stage biopharmaceutical company developing targeted combination therapies, today announced that its ceo shaun bagai will provide a corporate overview and update at the 43rd annual canaccord genuity growth conference on thursday, august 10, 2023 at 10:30 am et in boston, ma. register here to access the live webcast. mr. bagai will discuss recent company milestones, including the research c.
RNXT Ratings Summary
RNXT Quant Ranking